March 20, 2020 – Recent research by a team of Italian scientists examined the minor cannabinoid known as cannabimovone and its ability to engage with a receptor type that helps regulate both metabolic and immune functions with implications for future investigation into its use in the treatment of a variety of disease states.
February 21, 2020 – A new pre-clinical study from Cannabics Pharmaceuticals finds CBN, CBC and their acidic forms to be effective against human colon cancer cell lines.
February 20, 2020 – A new study out of Israel points to improved symptoms and a reduction of conventional medications for ADHD patients after cannabis consumption.
February 19, 2020 – Preliminary studies have shown how CBG attacks cancer cells, but this minor cannabinoid may improve chemotherapy-related symptoms and quality of life for cancer patients as well.
February 6, 2020 – Preliminary studies show promise of a non-intoxicating stem cell cannabinoid against cancer cell lines in both isolated and synergistic drug preparations.
January 24, 2020 – For nearly 40 years, the antimicrobial effects of cannabis-sourced compounds have been known to researchers. A new study sheds light on the particularly potent efficacy of an up-and-coming cannabinoid, CBG.
January 21, 2020 – Recent research has demonstrated the therapeutic potential of a flavonoid found in cannabis in the treatment of invasive pancreatic cancer, and clinical trials using a derivative of this flavonoid are set to start in spring.
January 17, 2020 – The far-reaching committee hearing was convened to discuss six cannabis reform proposals currently undergoing congressional consideration.
January 10, 2020 – Recently published work from an Italian research team describes how THCP may help scientists understand why some cannabis chemovars are more potent than others.
December 19, 2019 – Research is scarce when it comes to cannabis and cardiovascular concerns, but a new study from the UK suggests caution for consumers with pre-existing heart disease.